Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indazole-3-carboxamides and their use as Wnt/beta-catenin signaling pathway inhibitors

Indazole-3-carboxamides and their use as Wnt/beta-catenin signaling pathway inhibitors

US Patent 9802916 · Granted Oct 31, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of improving lung function2025
Methods of treating fibrosis2025
Methods of treating fibrosis2025
Gamma-diketones for treatment and prevention of aging skin and wrinkles2023
Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibit2023
Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof2023
Methods of using indazole-3-carboxamides and their use as Wnt/β-catenin signalin2023
γ-diketones as Wnt/β-catenin signaling pathway activators2023
2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses 2023
Method of treating fibrosis2023
Treatment of osteoarthritis2023
Methods of treating myeloproliferative disorders2022